-
Tobramycin and vestibulotoxicity: Retrospective analysis of four cases
Vonk, S. E. M., Weersink, E. J. M., Majoor, C. J. & Kemper, M. M., 22 Mar 2022, In: European journal of hospital pharmacy. ejhpharm-2020-002588.Research output: Contribution to journal › Article* › Academic › peer-review
-
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma
Eger, K., Pet, L., Weersink, E. J. M. & Bel, E. H., Jul 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 7, p. 2913-2915 3 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
VX14-661-110 study group, Jul 2021, In: lancet. Respiratory medicine. 9, 7, p. 733-746 14 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
